Geoff Macintyre

ORCID: 0000-0003-3906-467X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cancer Genomics and Diagnostics
  • Prostate Cancer Treatment and Research
  • Genomics and Phylogenetic Studies
  • Ovarian cancer diagnosis and treatment
  • Genetics, Bioinformatics, and Biomedical Research
  • Cancer-related molecular mechanisms research
  • Genomics and Chromatin Dynamics
  • Genetic factors in colorectal cancer
  • Epigenetics and DNA Methylation
  • Molecular Biology Techniques and Applications
  • Evolution and Genetic Dynamics
  • Gene expression and cancer classification
  • Genomic variations and chromosomal abnormalities
  • Bioinformatics and Genomic Networks
  • RNA modifications and cancer
  • Cancer, Lipids, and Metabolism
  • Genomics and Rare Diseases
  • Single-cell and spatial transcriptomics
  • DNA Repair Mechanisms
  • Prostate Cancer Diagnosis and Treatment
  • Chromosomal and Genetic Variations
  • Hormonal and reproductive studies
  • Cancer, Hypoxia, and Metabolism
  • Cancer Immunotherapy and Biomarkers
  • Nutrition, Genetics, and Disease

Spanish National Cancer Research Centre
2020-2025

Centro de Investigación del Cáncer
2025

Cancer Research UK
2015-2024

University of Cambridge
2015-2024

Cancer Research UK Cambridge Center
2017-2023

Centro Nacional de Investigaciones Científicas
2021-2023

The University of Melbourne
2009-2020

Data61
2009-2018

Peter MacCallum Cancer Centre
2010-2014

Walter and Eliza Hall Institute of Medical Research
2014

Moritz Gerstung Clemency Jolly Ignaty Leshchiner Stefan C. Dentro Santiago González and 95 more Daniel Rosebrock Thomas J. Mitchell Yulia Rubanova Pavana Anur Kaixian Yu Maxime Tarabichi Amit G. Deshwar Jeff Wintersinger Kortine Kleinheinz Ignacio Vázquez-Garćıa Kerstin Haase Lara Jerman Subhajit Sengupta Geoff Macintyre Salem Malikić Nilgun Donmez Dimitri Livitz Marek Cmero Jonas Demeulemeester Steven E. Schumacher Yu Fan Xiaotong Yao Juhee Lee Matthias Schlesner Paul C. Boutros David D.L. Bowtell Hongtu Zhu Gad Getz Marcin Imieliński Rameen Beroukhim S. Cenk Şahinalp Yuan Ji Martin Peifer Florian Markowetz Ville Mustonen Ke Yuan Wenyi Wang Quaid Morris Stefan C. Dentro Ignaty Leshchiner Moritz Gerstung Clemency Jolly Kerstin Haase Maxime Tarabichi Jeff Wintersinger Amit G. Deshwar Kaixian Yu Santiago González Yulia Rubanova Geoff Macintyre David J. Adams Pavana Anur Rameen Beroukhim Paul C. Boutros David D.L. Bowtell Peter J. Campbell Shaolong Cao Elizabeth L. Christie Marek Cmero Yupeng Cun Kevin J. Dawson Jonas Demeulemeester Nilgun Donmez Ruben M. Drews Roland Eils Yu Fan Matthew W. Fittall Dale W. Garsed Gad Getz Gavin Ha Marcin Imieliński Lara Jerman Yuan Ji Kortine Kleinheinz Juhee Lee Henry Lee-Six Dimitri Livitz Salem Malikić Florian Markowetz Iñigo Martincorena Thomas J. Mitchell Ville Mustonen Layla Oesper Martin Peifer Myron Peto Benjamin J. Raphael Daniel Rosebrock S. Cenk Şahinalp Adriana Salcedo Matthias Schlesner Steven E. Schumacher Subhajit Sengupta Ruian Shi Seung Jun Shin Oliver Spiro

Cancer develops through a process of somatic evolution

10.1038/s41586-019-1907-7 article EN cc-by Nature 2020-02-05
Yilong Li Nicola D. Roberts Jeremiah A. Wala Ofer Shapira Steven E. Schumacher and 95 more Kiran Kumar Ekta Khurana Sebastian M. Waszak Jan O. Korbel James E. Haber Marcin Imieliński Kadir C. Akdemir Eva G. Álvarez Adrian Baez‐Ortega Rameen Beroukhim Paul C. Boutros David D.L. Bowtell Benedikt Brors Kathleen H. Burns Peter J. Campbell Kin Chan Ken Chen Isidro Cortés‐Ciriano Ana Dueso-Barroso Andrew Dunford Paul A. Edwards Xavier Estivill Dariush Etemadmoghadam Lars Feuerbach J. Lynn Fink Milana Frenkel‐Morgenstern Dale W. Garsed Mark Gerstein Dmitry A. Gordenin David Haan James E. Haber Julian M. Hess Barbara Hutter Marcin Imieliński David Jones Young Seok Ju Marat D. Kazanov Leszek J. Klimczak Youngil Koh Jan O. Korbel Kiran Kumar Eunjung Alice Lee Jake June-Koo Lee Yilong Li Andy G. Lynch Geoff Macintyre Florian Markowetz Iñigo Martincorena Alexander Martinez‐Fundichely Matthew Meyerson Satoru Miyano Hidewaki Nakagawa Fábio C. P. Navarro Stephan Ossowski Peter J. Park John V. Pearson Montserrat Puiggròs Karsten Rippe Nicola D. Roberts Steven A. Roberts Bernardo Rodríguez–Martín Steven E. Schumacher Ralph Scully Mark Shackleton Nikos Sidiropoulos Lina Sieverling Chip Stewart David Torrents José M. C. Tubío Izar Villasante Nicola Waddell Jeremiah A. Wala Joachim Weischenfeldt Lixing Yang Xiaotong Yao Sung-Soo Yoon Jorge Zamora Cheng‐Zhong Zhang Joachim Weischenfeldt Rameen Beroukhim Peter J. Campbell Lauri A. Aaltonen Federico Abascal Adam Abeshouse Hiroyuki Aburatani David J. Adams Nishant Agrawal Keun Soo Ahn Sung‐Min Ahn Hiroshi Aikata Rehan Akbani Kadir C. Akdemir Hikmat Al‐Ahmadie Sultan T. Al‐Sedairy Fátima Al‐Shahrour

Abstract A key mutational process in cancer is structural variation, which rearrangements delete, amplify or reorder genomic segments that range size from kilobases to whole chromosomes 1–7 . Here we develop methods group, classify and describe somatic variants, using data the Pan-Cancer Analysis of Whole Genomes (PCAWG) Consortium International Cancer Genome (ICGC) The Atlas (TCGA), aggregated whole-genome sequencing 2,658 cancers across 38 tumour types 8 Sixteen signatures variation...

10.1038/s41586-019-1913-9 article EN cc-by Nature 2020-02-05
Isidro Cortés‐Ciriano Jake June-Koo Lee Ruibin Xi Dhawal Jain Youngsook L. Jung and 95 more Lixing Yang Dmitry A. Gordenin Leszek J. Klimczak Cheng‐Zhong Zhang David Pellman Kadir C. Akdemir Eva G. Álvarez Adrian Baez‐Ortega Rameen Beroukhim Paul C. Boutros David D.L. Bowtell Benedikt Brors Kathleen H. Burns Peter J. Campbell Kin Chan Ken Chen Isidro Cortés‐Ciriano Ana Dueso-Barroso Andrew Dunford Paul A. Edwards Xavier Estivill Dariush Etemadmoghadam Lars Feuerbach J. Lynn Fink Milana Frenkel‐Morgenstern Dale W. Garsed Mark Gerstein Dmitry A. Gordenin David Haan James E. Haber Julian M. Hess Barbara Hutter Marcin Imieliński David Jones Young Seok Ju Marat D. Kazanov Leszek J. Klimczak Youngil Koh Jan O. Korbel Kiran Kumar Eunjung Alice Lee Jake June-Koo Lee Yilong Li Andy G. Lynch Geoff Macintyre Florian Markowetz Iñigo Martincorena Alexander Martinez‐Fundichely Satoru Miyano Hidewaki Nakagawa Fábio C. P. Navarro Stephan Ossowski Peter J. Park John V. Pearson Montserrat Puiggròs Karsten Rippe Nicola D. Roberts Steven A. Roberts Bernardo Rodríguez–Martín Steven E. Schumacher Ralph Scully Mark Shackleton Nicholas D. Sidiropoulos Lina Sieverling Chip Stewart David Torrents José M. C. Tubío Izar Villasante Nicola Waddell Jeremiah A. Wala Joachim Weischenfeldt Lixing Yang Xiaotong Yao Sung-Soo Yoon Jorge Zamora Cheng‐Zhong Zhang Peter J. Park Lauri A. Aaltonen Federico Abascal Adam Abeshouse Hiroyuki Aburatani David J. Adams Nishant Agrawal Keun Soo Ahn Sung‐Min Ahn Hiroshi Aikata Rehan Akbani Kadir C. Akdemir Hikmat Al‐Ahmadie Sultan T. Al‐Sedairy Fátima Al‐Shahrour Malik Alawi Monique Albert Kenneth Aldape Ludmil B. Alexandrov

Chromothripsis is a mutational phenomenon characterized by massive, clustered genomic rearrangements that occurs in cancer and other diseases. Recent studies selected types have suggested chromothripsis may be more common than initially inferred from low-resolution copy-number data. Here, as part of the Pan-Cancer Analysis Whole Genomes (PCAWG) Consortium International Cancer Genome (ICGC) The Atlas (TCGA), we analyze patterns across 2,658 tumors 38 using whole-genome sequencing We find...

10.1038/s41588-019-0576-7 article EN cc-by Nature Genetics 2020-02-05
Stefan C. Dentro Ignaty Leshchiner Kerstin Haase Maxime Tarabichi Jeff Wintersinger and 95 more Amit G. Deshwar Kaixian Yu Yulia Rubanova Geoff Macintyre Jonas Demeulemeester Ignacio Vázquez-Garćıa Kortine Kleinheinz Dimitri Livitz Salem Malikić Nilgun Donmez Subhajit Sengupta Pavana Anur Clemency Jolly Marek Cmero Daniel Rosebrock Steven E. Schumacher Yu Fan Matthew W. Fittall Ruben M. Drews Xiaotong Yao Thomas B.K. Watkins Ju‐Hee Lee Matthias Schlesner Hongtu Zhu David J. Adams Nicholas McGranahan Charles Swanton Gad Getz Paul C. Boutros Marcin Imieliński Rameen Beroukhim S. Cenk Şahinalp Yuan Ji Martin Peifer Iñigo Martincorena Florian Markowetz Ville Mustonen Ke Yuan Moritz Gerstung Paul T. Spellman Wenyi Wang Quaid Morris David C. Wedge Peter Van Loo Stefan C. Dentro Ignaty Leshchiner Moritz Gerstung Clemency Jolly Kerstin Haase Maxime Tarabichi Jeff Wintersinger Amit G. Deshwar Kaixian Yu Santiago González Yulia Rubanova Geoff Macintyre Jonas Demeulemeester David J. Adams Pavana Anur Rameen Beroukhim Paul C. Boutros David D.L. Bowtell Peter J. Campbell Shaolong Cao Elizabeth L. Christie Marek Cmero Yupeng Cun Kevin J. Dawson Nilgun Donmez Ruben M. Drews Roland Eils Yu Fan Matthew W. Fittall Dale W. Garsed Gad Getz Gavin Ha Marcin Imieliński Lara Jerman Yuan Ji Kortine Kleinheinz Juhee Lee Henry Lee-Six Dimitri Livitz Salem Malikić Florian Markowetz Iñigo Martincorena Thomas J. Mitchell Ville Mustonen Layla Oesper Martin Peifer Myron Peto Benjamin J. Raphael Daniel Rosebrock S. Cenk Şahinalp Adriana Salcedo

Intra-tumor heterogeneity (ITH) is a mechanism of therapeutic resistance and therefore an important clinical challenge. However, the extent, origin, drivers ITH across cancer types are poorly understood. To address this, we extensively characterize whole-genome sequences 2,658 samples spanning 38 types. Nearly all informative (95.1%) contain evidence distinct subclonal expansions with frequent branching relationships between subclones. We observe positive selection driver mutations most...

10.1016/j.cell.2021.03.009 article EN cc-by Cell 2021-04-01
Bernardo Rodríguez–Martín Eva G. Álvarez Adrian Baez‐Ortega Jorge Zamora Fran Supek and 95 more Jonas Demeulemeester Martín Santamarina Young Seok Ju Javier Temes Daniel García‐Souto Harald Detering Yilong Li Jorge Rodríguez‐Castro Ana Dueso-Barroso Alicia L. Bruzos Stefan C. Dentro Miguel G. Blanco Gianmarco Contino Daniel Ardeljan Marta Tojo Nicola D. Roberts Sonia Zumalave Paul A. Edwards Joachim Weischenfeldt Montserrat Puiggròs Zechen Chong Ken Chen Eunjung Alice Lee Jeremiah A. Wala Keiran Raine Adam P. Butler Sebastian M. Waszak Fábio C. P. Navarro Steven E. Schumacher Jean Monlong Francesco Maura Niccolò Bolli Guillaume Bourque Mark Gerstein Peter J. Park David C. Wedge Rameen Beroukhim David Torrents Jan O. Korbel Iñigo Martincorena Rebecca C. Fitzgerald Peter Van Loo Haig H. Kazazian Kathleen H. Burns Kadir C. Akdemir Eva G. Álvarez Adrian Baez‐Ortega Rameen Beroukhim Paul C. Boutros David D.L. Bowtell Benedikt Brors Kathleen H. Burns Peter J. Campbell Kin Chan Ken Chen Isidro Cortés‐Ciriano Ana Dueso-Barroso Andrew Dunford Paul A. Edwards Xavier Estivill Dariush Etemadmoghadam Lars Feuerbach J. Lynn Fink Milana Frenkel‐Morgenstern Dale W. Garsed Mark Gerstein Dmitry A. Gordenin David Haan James E. Haber Julian M. Hess Barbara Hutter Marcin Imieliński David Jones Young Seok Ju Marat D. Kazanov Leszek J. Klimczak Youngil Koh Jan O. Korbel Kiran Kumar Eunjung Alice Lee Jake June-Koo Lee Yilong Li Andy G. Lynch Geoff Macintyre Florian Markowetz Iñigo Martincorena Alexander Martinez‐Fundichely Matthew Meyerson Satoru Miyano Hidewaki Nakagawa Fábio C. P. Navarro Stephan Ossowski Peter J. Park John V. Pearson Montserrat Puiggròs

Abstract About half of all cancers have somatic integrations retrotransposons. Here, to characterize their role in oncogenesis, we analyzed the patterns and mechanisms retrotransposition 2,954 cancer genomes from 38 histological subtypes within framework Pan-Cancer Analysis Whole Genomes (PCAWG) project. We identified 19,166 somatically acquired events, which affected 35% samples spanned a range event types. Long interspersed nuclear element (LINE-1; L1 hereafter) insertions emerged as first...

10.1038/s41588-019-0562-0 article EN cc-by Nature Genetics 2020-02-05

Abstract Tumour heterogeneity in primary prostate cancer is a well-established phenomenon. However, how the subclonal diversity of tumours changes during metastasis and progression to lethality poorly understood. Here we reveal precise direction metastatic spread across four lethal patients using whole-genome ultra-deep targeted sequencing longitudinally collected tumours. We find one case surgical bed causing local recurrence, another cross-metastatic site seeding combining with dynamic...

10.1038/ncomms7605 article EN cc-by Nature Communications 2015-04-01
Kadir C. Akdemir Victoria T. Le Sahaana Chandran Yilong Li Roel G.W. Verhaak and 95 more Rameen Beroukhim Peter J. Campbell Lynda Chin Jesse R. Dixon P. Andrew Futreal Kadir C. Akdemir Eva G. Álvarez Adrian Baez‐Ortega Paul C. Boutros David D.L. Bowtell Benedikt Brors Kathleen H. Burns Peter J. Campbell Kin Chan Ken Chen Isidro Cortés‐Ciriano Ana Dueso-Barroso Andrew Dunford Paul A. Edwards Xavier Estivill Dariush Etemadmoghadam Lars Feuerbach J. Lynn Fink Milana Frenkel‐Morgenstern Dale W. Garsed Mark Gerstein Dmitry A. Gordenin David Haan James E. Haber Julian M. Hess Barbara Hutter Marcin Imieliński David Jones Young Seok Ju Marat D. Kazanov Leszek J. Klimczak Youngil Koh Jan O. Korbel Kiran Kumar Eunjung Alice Lee Jake June-Koo Lee Yilong Li Andy G. Lynch Geoff Macintyre Florian Markowetz Iñigo Martincorena Alexander Martinez‐Fundichely Matthew Meyerson Satoru Miyano Hidewaki Nakagawa Fábio C. P. Navarro Stephan Ossowski Peter J. Park John V. Pearson Montserrat Puiggròs Karsten Rippe Nicola D. Roberts Steven A. Roberts Bernardo Rodríguez–Martín Steven E. Schumacher Ralph Scully Mark Shackleton Nicholas D. Sidiropoulos Lina Sieverling Chip Stewart David Torrents José M. C. Tubío Izar Villasante Nicola Waddell Jeremiah A. Wala Joachim Weischenfeldt Lixing Yang Xiaotong Yao Sung-Soo Yoon Jorge Zamora Cheng‐Zhong Zhang Lauri A. Aaltonen Federico Abascal Adam Abeshouse Hiroyuki Aburatani David J. Adams Nishant Agrawal Keun Soo Ahn Sung‐Min Ahn Hiroshi Aikata Rehan Akbani Kadir C. Akdemir Hikmat Al‐Ahmadie Sultan T. Al‐Sedairy Fátima Al‐Shahrour Malik Alawi Monique Albert Kenneth Aldape Ludmil B. Alexandrov Adrian Ally

Chromatin is folded into successive layers to organize linear DNA. Genes within the same topologically associating domains (TADs) demonstrate similar expression and histone-modification profiles, boundaries separating different have important roles in reinforcing stability of these features. Indeed, domain disruptions human cancers can lead misregulation gene expression. However, frequency remains unclear. Here, as part Pan-Cancer Analysis Whole Genomes (PCAWG) Consortium International...

10.1038/s41588-019-0564-y article EN cc-by Nature Genetics 2020-02-05

Emerging evidence suggests that poor glycemic control mediates post-translational modifications to the H3 histone tail. We are only beginning understand dynamic role of some diverse epigenetic changes mediated by hyperglycemia at single loci, yet elevated glucose levels thought regulate genome-wide changes, and this still remains poorly understood. In article we describe H3K9/K14 hyperacetylation DNA methylation maps conferred in primary human vascular cells. Chromatin immunoprecipitation...

10.1101/gr.116095.110 article EN cc-by-nc Genome Research 2011-09-02

Abstract Motivation: Determining the functional impact of non-coding disease-associated single nucleotide polymorphisms (SNPs) identified by genome-wide association studies (GWAS) is challenging. Many these SNPs are likely to be regulatory (rSNPs): variations which affect ability a transcription factor (TF) bind DNA. However, experimental procedures for identifying rSNPs expensive and labour intensive. Therefore, in silico methods required rSNP prediction. By scoring two alleles with TF...

10.1093/bioinformatics/btq378 article EN cc-by-nc Bioinformatics 2010-09-04

The Illumina HumanMethylation450 BeadChip (HM450K) measures the DNA methylation of 485,512 CpGs in human genome. technology relies on hybridization genomic fragments to probes chip. However, certain factors may compromise ability measure using array such as single nucleotide polymorphisms (SNPs), small insertions and deletions (INDELs), repetitive DNA, regions with reduced complexity. Currently, there is no clear method or pipeline for determining which HM450K bead should be retained...

10.1186/1471-2164-15-51 article EN cc-by BMC Genomics 2014-01-01
Lina Sieverling Chen Hong Sandra D. Koser Philip Ginsbach Kortine Kleinheinz and 95 more Barbara Hutter Delia M. Braun Isidro Cortés‐Ciriano Ruibin Xi Rolf Kabbe Peter J. Park Roland Eils Matthias Schlesner Kadir C. Akdemir Eva G. Álvarez Adrian Baez‐Ortega Rameen Beroukhim Paul C. Boutros David D.L. Bowtell Benedikt Brors Kathleen H. Burns Peter J. Campbell Kin Chan Ken Chen Isidro Cortés‐Ciriano Ana Dueso-Barroso Andrew Dunford Paul A. Edwards Xavier Estivill Dariush Etemadmoghadam Lars Feuerbach J. Lynn Fink Milana Frenkel‐Morgenstern Dale W. Garsed Mark Gerstein Dmitry A. Gordenin David Haan James E. Haber Julian M. Hess Barbara Hutter Marcin Imieliński David Jones Young Seok Ju Marat D. Kazanov Leszek J. Klimczak Youngil Koh Jan O. Korbel Kiran Kumar Eunjung Alice Lee Jake June-Koo Lee Yilong Li Andy G. Lynch Geoff Macintyre Florian Markowetz Iñigo Martincorena Alexander Martinez‐Fundichely Matthew Meyerson Satoru Miyano Hidewaki Nakagawa Fábio C. P. Navarro Stephan Ossowski Peter J. Park John V. Pearson Montserrat Puiggròs Karsten Rippe Nicola D. Roberts Steven A. Roberts Bernardo Rodríguez–Martín Steven E. Schumacher Ralph Scully Mark Shackleton Nicholas D. Sidiropoulos Lina Sieverling Chip Stewart David Torrents José M. C. Tubío Izar Villasante Nicola Waddell Jeremiah A. Wala Joachim Weischenfeldt Lixing Yang Xiaotong Yao Sung-Soo Yoon Jorge Zamora Cheng‐Zhong Zhang Benedikt Brors Karsten Rippe David Jones Lars Feuerbach Lauri A. Aaltonen Federico Abascal Adam Abeshouse Hiroyuki Aburatani David J. Adams Nishant Agrawal Keun Soo Ahn Sung-Min Ahn Hiroshi Aikata Rehan Akbani Kadir C. Akdemir

Abstract Cancers require telomere maintenance mechanisms for unlimited replicative potential. They achieve this through TERT activation or alternative lengthening associated with ATRX DAXX loss. Here, as part of the ICGC/TCGA Pan-Cancer Analysis Whole Genomes (PCAWG) Consortium , we dissect whole-genome sequencing data over 2500 matched tumor-control samples from 36 different tumor types aggregated within to characterize genomic footprints these mechanisms. While content tumors mutations...

10.1038/s41467-019-13824-9 article EN cc-by Nature Communications 2020-02-05

The objective of this study was to determine whether microRNA (miRNA) profiling urine could identify the presence urothelial carcinoma bladder (UCB) and compare its performance characteristics that cystoscopy.In discovery cohort we screened 81 patients, which included 21 benign controls, 30 non-recurrers patients with active cancer (recurrers), using a panel 12 miRNAs. Data analysis performed machine learning approach Support Vector Machine classifier Student's t-test feature selection...

10.1038/bjc.2015.472 article EN cc-by-nc-sa British Journal of Cancer 2016-01-26

Abstract The drivers of recurrence and resistance in ovarian high grade serous carcinoma remain unclear. We investigate the acquisition by collecting tumour biopsies from a cohort 276 women with relapsed BriTROC-1 study. Panel sequencing shows close concordance between diagnosis relapse, only four discordant cases. There is also very strong copy number no significant difference purity, ploidy or focal somatic alterations, even when stratified platinum sensitivity prior chemotherapy lines....

10.1038/s41467-023-39867-7 article EN cc-by Nature Communications 2023-07-20

Methods for detecting somatic genome rearrangements in tumours using next-generation sequencing are vital cancer genomics. Available algorithms use one or more sources of evidence, such as read depth, paired-end reads split to predict structural variants. However, the problem remains challenging due significant computational burden and high false-positive false-negative rates.In this article, we present Socrates (SOft Clip re-alignment To idEntify Structural variants), a highly efficient...

10.1093/bioinformatics/btt767 article EN cc-by-nc Bioinformatics 2014-01-02
Aline Talhouk Joshy George Chen Wang Timothy Budden Tuan Zea Tan and 95 more Derek S. Chiu Stefan Kommoss Huei San Leong Stephanie Chen Maria P. Intermaggio C. Blake Gilks Tayyebeh M. Nazeran Mila Volchek Wafaa Elatre Rex C. Bentley Janine Senz Amy Lum Veronica Chow Hanwei Sudderuddin Robertson Mackenzie Samuel C.Y. Leong Geyi Liu Dustin Johnson Billy Chen AOCS Group Jennifer Alsop Susana Banerjee Sabine Behrens Clara Bodelón Alison H. Brand Louise A. Brinton Michael E. Carney Yoke-Eng Chiew Kara L. Cushing‐Haugen Cezary Cybulski Darren Ennis Sián Fereday Renée T. Fortner Jesús García-Donás Aleksandra Gentry‐Maharaj Rosalind Glasspool Teodora Goranova Casey S. Greene Paul Haluska Holly R. Harris Joy Hendley Brenda Y. Hernandez Esther Herpel Mercedes Jimenez‐Liñan Chloe Karpinskyj Scott H. Kaufmann Gary L. Keeney Catherine J. Kennedy Martin Köbel Jennifer M. Koziak Melissa C. Larson Jenny Lester Liz-Anne Lewsley Jolanta Lissowska Jan Lubiński Hugh Luk Geoff Macintyre Sven� Mahner Iain A. McNeish Janusz Menkiszak Nikilyn Nevins Ana Osório Oleg Oszurek José Palacios Samantha Hinsley Celeste Leigh Pearce Malcolm C. Pike Anna Piskorz Isabelle Ray‐Coquard Valerie Rhenius Cristina Rodríguez‐Antona Raghwa Sharma Mark E. Sherman Dilrini De Silva Naveena Singh Hans‐Peter Sinn Dennis J. Slamon Honglin Song Helen Steed Euan A. Stronach Pamela J. Thompson Aleksandra Tołoczko Britton Trabert Nadia Traficante Chiu-Chen Tseng Martin Widschwendter Lynne R. Wilkens Stacey J. Winham Boris Winterhoff Alicia Beeghly‐Fadiel Javier Benı́tez Andrew Berchuck James D. Brenton Robert Brown Jenny Chang‐Claude

Abstract Purpose: Gene expression–based molecular subtypes of high-grade serous tubo-ovarian cancer (HGSOC), demonstrated across multiple studies, may provide improved stratification for molecularly targeted trials. However, evaluation clinical utility has been hindered by nonstandardized methods, which are not applicable in a setting. We sought to generate grade minimal gene set assay classification individual tumor specimens into HGSOC and confirm previously reported subtype-associated...

10.1158/1078-0432.ccr-20-0103 article EN Clinical Cancer Research 2020-06-17

Abstract While most testicular germ cell tumours (TGCTs) exhibit exquisite sensitivity to platinum chemotherapy, ~10% are resistant. To gain insight into the underlying mechanisms, we undertake whole exome sequencing and copy number analysis in 40 from 26 cases with platinum-resistant TGCT, combine this published genomic data on an additional 624 TGCTs. We integrate analyses for driver mutations, mutational burden, global, arm-level focal (CN) events, SNV CN signatures. Albeit preliminary...

10.1038/s41467-020-15768-x article EN cc-by Nature Communications 2020-05-04

Abstract Cancer cells often exhibit DNA copy number aberrations and can vary widely in their ploidy. Correct estimation of the ploidy single-cell genomes is paramount for downstream analysis. Based only on sequencing information, scAbsolute achieves accurate unbiased measurement replication status, including whole-genome duplications. We demonstrate scAbsolute’s capabilities using experimental cell multiplets, a FUCCI cycle expression system, benchmark against state-of-the-art methods....

10.1186/s13059-024-03204-y article EN cc-by Genome biology 2024-03-04

Summary Cancer develops through a process of somatic evolution. Here, we use whole-genome sequencing 2,778 tumour samples from 2,658 donors to reconstruct the life history, evolution mutational processes, and driver mutation sequences 39 cancer types. The early phases oncogenesis are driven by point mutations in small set genes, often including biallelic inactivation suppressors. Early is also characterised specific copy number gains, such as trisomy 7 glioblastoma or isochromosome 17q...

10.1101/161562 preprint EN bioRxiv (Cold Spring Harbor Laboratory) 2017-07-11
Coming Soon ...